Abiopharma

Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation

New Form 8-K - Aclaris Therapeutics, Inc. Filed: 2025-06-30 AccNo: 0001558370-25-008984 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Oncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development Strategy

Tonix Pharmaceuticals Announces Inclusion in the Russell 3000® and Russell 2000® Indexes

Bausch + Lomb Will Release Second-Quarter 2025 Financial Results on July 30 and Hold Investor Day on Nov. 13

Protalix BioTherapeutics Added to Russell3000® and 2000 Indexes®

New Form 8-K - Vicarious Surgical Inc. Filed: 2025-06-30 AccNo: 0001213900-25-059237 Size: 615 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 7.01: Regulation FD Disclosure …

New Form 6-K - GSK plc Filed: 2025-06-30 AccNo: 0001654954-25-007495 Size: 1 MB

Vicarious Surgical Inc. - Vicarious Surgical Announces Election of New Directors

Vicarious Surgical Announces Election of New Directors

Grey symbol attribute type Security_Name was changed. Previous value: MASTERWORKS 146 LLC A. New value: G MED INNVATONS HLD WTS.

New Form 6-K - HUTCHMED Filed: 2025-06-30 AccNo: 0001648257-25-000047 Size: 130 KB

New Form 8-K - Traws Pharma, Inc. Filed: 2025-06-30 AccNo: 0001104659-25-063793 Size: 11 MB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Change in Interest - Lee Keck Keong

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Change in Interest - Lee Jun Yih